# CNS Pharmaceuticals, Inc.: filings

CNSP · Nasdaq · CIK 1729427 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnsp.md) · [Financials](/companies/cnsp/financials.md) · [Filings](/companies/cnsp/filings.md) · [Insiders](/companies/cnsp/insiders.md)

## Reports and events: 164 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 100, 4 68, CORRESP 43, 10-Q 21, 3 15, EFFECT 12, UPLOAD 12, S-1/A 10, 424B5 8, DEF 14A 8, S-1 8, 10-K 7, 4/A 7, 10-K/A 6, 424B3 5, 424B4 5, PRE 14A 5, S-3 5, SC 13G 4, SCHEDULE 13G/A 4, 1-A/A 3, 8-K/A 3, DRS 3, FWP 3, S-8 3, SCHEDULE 13G 3, DEFA14A 2, SC 13G/A 2, 1-A 1, 1-A-W 1, 8-A12B 1, ARS 1, C 1, C-AR 1, CERT 1, C-TR 1, C-U 1, D 1, DEFR14A 1, DOS 1, DRSLTR 1, RW 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 12:00 ET | [8-K](/filings/0001683168-26-007552.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-26-007552 |
| 2026-08-21 | 21:15 ET | [DEF 14A](/filings/0001683168-26-006660.md) | Proxy statement, period 2026-09-30 | 0001683168-26-006660 |
| 2026-08-12 | 11:56 ET | [10-Q](/filings/0001683168-26-006224.md) | Quarterly report, period 2026-06-30 | 0001683168-26-006224 |
| 2026-07-02 | 11:30 ET | [8-K](/filings/0001683168-26-005233.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-005233 |
| 2026-05-14 | 11:55 ET | [10-Q](/filings/0001683168-26-003847.md) | Quarterly report, period 2026-03-31 | 0001683168-26-003847 |
| 2026-05-04 | 11:05 ET | [8-K](/filings/0001683168-26-003432.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-003432 |
| 2026-04-30 | 20:30 ET | [10-K/A](/filings/0001683168-26-003374.md) | Annual report, amended, period 2025-12-31 | 0001683168-26-003374 |
| 2026-03-31 | 20:30 ET | [10-K](/filings/0001683168-26-002550.md) | Annual report, period 2025-12-31 | 0001683168-26-002550 |
| 2026-03-11 | 12:35 ET | [8-K](/filings/0001683168-26-001664.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-001664 |
| 2026-03-02 | 22:00 ET | [8-K](/filings/0001683168-26-001413.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-001413 |
| 2026-02-17 | 13:35 ET | [8-K](/filings/0001683168-26-001066.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-001066 |
| 2025-12-17 | 13:43 ET | [8-K](/filings/0001683168-25-009208.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-25-009208 |
| 2025-11-21 | 22:19 ET | [8-K](/filings/0001683168-25-008624.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-25-008624 |
| 2025-11-14 | 22:10 ET | [10-Q](/filings/0001683168-25-008466.md) | Quarterly report, period 2025-09-30 | 0001683168-25-008466 |
| 2025-10-24 | 20:00 ET | [DEF 14A](/filings/0001683168-25-007760.md) | Proxy statement, period 2025-11-17 | 0001683168-25-007760 |
| 2025-08-14 | 20:02 ET | [10-Q](/filings/0001683168-25-006162.md) | Quarterly report, period 2025-06-30 | 0001683168-25-006162 |
| 2025-07-22 | 20:39 ET | [8-K](/filings/0001683168-25-005284.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-005284 |
| 2025-07-15 | 21:19 ET | [8-K](/filings/0001683168-25-005129.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-005129 |
| 2025-05-15 | 21:00 ET | [10-Q](/filings/0001683168-25-003733.md) | Quarterly report, period 2025-03-31 | 0001683168-25-003733 |
| 2025-05-15 | 22:52 ET | [8-K](/filings/0001683168-25-003575.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-25-003575 |
| 2025-05-12 | 10:03 ET | [S-1/A](/filings/0001683168-25-003362.md) | Registration statement, amended | 0001683168-25-003362 |
| 2025-04-30 | 20:30 ET | [10-K/A](/filings/0001683168-25-002998.md) | Annual report, amended, period 2024-12-31 | 0001683168-25-002998 |
| 2025-04-14 | 21:01 ET | [S-1](/filings/0001683168-25-002548.md) | Registration statement | 0001683168-25-002548 |
| 2025-04-09 | 19:32 ET | [8-K](/filings/0001683168-25-002373.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-002373 |
| 2025-03-31 | 21:12 ET | [8-K](/filings/0001683168-25-002140.md) | 8.01 Other events | 0001683168-25-002140 |
| 2025-03-31 | 21:11 ET | [10-K](/filings/0001683168-25-002139.md) | Annual report, period 2024-12-31 | 0001683168-25-002139 |
| 2025-03-20 | 21:15 ET | [8-K](/filings/0001683168-25-001754.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001754 |
| 2025-02-21 | 22:00 ET | [8-K](/filings/0001683168-25-001174.md) | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-001174 |
| 2025-01-03 | 22:00 ET | [8-K](/filings/0001683168-25-000077.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-000077 |
| 2024-12-11 | 17:24 ET | [8-K](/filings/0001683168-24-008640.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-008640 |
| 2024-12-03 | 00:34 ET | [8-K](/filings/0001683168-24-008464.md) | 5.07 Shareholder vote results | 0001683168-24-008464 |
| 2024-11-14 | 22:00 ET | [10-Q](/filings/0001683168-24-008125.md) | Quarterly report, period 2024-09-30 | 0001683168-24-008125 |
| 2024-11-01 | 13:00 ET | [8-K](/filings/0001683168-24-007533.md) | 8.01 Other events | 0001683168-24-007533 |
| 2024-10-28 | 20:15 ET | [DEF 14A](/filings/0001683168-24-007416.md) | Proxy statement, period 2024-11-26 | 0001683168-24-007416 |
| 2024-10-24 | 21:27 ET | [8-K](/filings/0001683168-24-007371.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007371 |
| 2024-10-23 | 12:02 ET | [8-K](/filings/0001683168-24-007304.md) | 8.01 Other events | 0001683168-24-007304 |
| 2024-09-18 | 20:30 ET | [8-K](/filings/0001683168-24-006495.md) | 3.01 Delisting notice | 0001683168-24-006495 |
| 2024-09-12 | 12:58 ET | [8-K](/filings/0001683168-24-006318.md) | 3.01 Delisting notice | 0001683168-24-006318 |
| 2024-08-14 | 21:22 ET | [10-Q](/filings/0001683168-24-005711.md) | Quarterly report, period 2024-06-30 | 0001683168-24-005711 |
| 2024-08-07 | 11:30 ET | [8-K](/filings/0001683168-24-005311.md) | 8.01 Other events | 0001683168-24-005311 |
| 2024-08-02 | 20:11 ET | [SC 13D](/filings/0001193125-24-192870.md) | Ownership report, active investor | 0001193125-24-192870 |
| 2024-07-30 | 21:13 ET | [8-K](/filings/0001683168-24-005145.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-005145 |
| 2024-07-30 | 11:00 ET | [8-K](/filings/0001683168-24-005118.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-005118 |
| 2024-07-26 | 12:00 ET | [8-K](/filings/0001683168-24-005070.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001683168-24-005070 |
| 2024-07-24 | 13:30 ET | [8-K](/filings/0001683168-24-005023.md) | 3.01 Delisting notice | 0001683168-24-005023 |
| 2024-07-19 | 21:12 ET | [S-1/A](/filings/0001683168-24-004962.md) | Registration statement, amended | 0001683168-24-004962 |
| 2024-07-12 | 20:30 ET | [S-1](/filings/0001683168-24-004799.md) | Registration statement | 0001683168-24-004799 |
| 2024-07-12 | 23:38 ET | [8-K/A](/filings/0001683168-24-004772.md) | 8.01 Other events | 0001683168-24-004772 |
| 2024-07-09 | 15:25 ET | [8-K](/filings/0001683168-24-004708.md) | 8.01 Other events | 0001683168-24-004708 |
| 2024-07-03 | 20:56 ET | [8-K](/filings/0001683168-24-004667.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004667 |

Page 1 of 4. [Older](/companies/cnsp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.